Evidence map›Paper›PMID 31111094›Full record

ArticleRomanian journal of anaesthesia and intensive care2019

The role of ramosetron in the prevention of post-spinal shivering in obstetric patients. A prospective randomized double blind study.

Rohit Kumar Varshney, Megha Garg, Kali Kapoor, Gurdeep Singh Jheetay

Registry-linked trialAbstract read
In one paragraph

Article in Romanian journal of anaesthesia and intensive care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04654429 (Does Higher Operation Theatre Ambient Temperature and Intravenous Ondansetron Prophylaxis Reduce Incidence of Post-spinal Shivering in Obstetric Population? A Double-blind, Randomised, Factorial Study.), which is not on this map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04654429 phase4unknown statusnot on this mapstarted 2020, after this paper: background citation

Does Higher Operation Theatre Ambient Temperature and Intravenous Ondansetron Prophylaxis Reduce Incidence of Post-spinal Shivering in Obstetric Population? A Double-blind, Randomised, Factorial Study.

TypeinterventionalSponsorDr Lim Siu MinRan2020 to 2022Enrolled628ConditionsTemperature Change, Body, Chills, Tremor, Nausea, PostoperativeArmsIV Ondansetron 4mg, Higher OT temperature range, Placebo, Lower OT temperature Range
3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rohit Kumar VarshneyDepartment of Anaesthesia, Teerthankar Mahaveer Medical College, Moradabad, U.P., India.
Megha GargDepartment of Pharmacy, Teerthanker Mahaveer College of Pharmacy, Moradabad, U.P., India.
Kali KapoorDepartment of Anaesthesia, Teerthankar Mahaveer Medical College, Moradabad, U.P., India.
Gurdeep Singh JheetayDepartment of Anaesthesia, Teerthankar Mahaveer Medical College, Moradabad, U.P., India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimIntra/post-operative shivering is frequently observed in parturients posted for elective cesarean delivery (C/D) under spinal anaesthesia. Several studies have advocated the anti-shivering effect of 5-HT

methodThe study comprised 80 parturients of the American Society of Anaesthesiologists (ASA) physical status I/II, posted for elective C/D under spinal anaesthesia who were randomly divided into 2 equal groups; Group N: 0.9% normal saline (4 ml) immediately before induction of spinal anaesthesia and Group R: ramosetron (0.3 mg) intravenously diluted to 4 ml volume. Shivering at any time on a (0-4) scale and total dose of tramadol required for its treatment was recorded. The study also includes the recording of haemodynamic parameters and the incidence of early onset nausea and vomiting.

resultsStatistically significant data was obtained while comparing incidence of shivering and maximum shivering at any time (P = 0.001). A lower incidence of early onset nausea and decreased total dose of tramadol was also observed in the ramosetron group.

conclusionRamosetron (0.3 mg) is advocated to be an effective drug in preventing post-spinal shivering among parturients posted for elective C/D. Moreover, its role in preventing maternal nausea together with better haemodynamic parameters further supported the advantageous role of ramosetron in our group of patients.

Indexed as

cesarean sectionpost-spinal shiveringramosetron

Identifiers

PMID31111094
PMCPMC6502278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.